CSBR
Champions Oncology, Inc.
Biotechnology · Healthcare · United States
4.93
close · 2026-08-28
value
24
cheaper than peers24
quality
50
stronger fundamentals50
ranked against
Biotechnology (commercial)
value
quality
151 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.18× | 97 |
| price to book | 17.36× | 13 |
| forward P/E | 49.30× | 13 |
| EV to EBITDA | 201.80× | 10 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | -3.8% | 76 |
| return on equity | -30.0% | 66 |
| revenue growth | 12.0% | 44 |
| debt to equity | 113.0% | 22 |
4 of 4 measures available
Facts
| market cap | $68M |
| free cash flow | -$4.3M |
| employees | 214 |
| first trade | 2007-02-02 |
| next earnings | 2026-07-27 |
| fundamentals updated | 2026-08-17 |